# Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

> **NCT04802070** · PHASE1 · COMPLETED · sponsor: **Prof. Franca Fagioli** · enrollment: 7 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Autologous CIK

## Key facts

- **NCT ID:** NCT04802070
- **Lead sponsor:** Prof. Franca Fagioli
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04802070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04802070, "Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04802070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*